1.World Health Organization (2008) The Global Burden of Disease: 2004 Update. Switzerland: WHO.
2.Lee JM, Pilli S, Gebremariam A et al. (2010) Getting heavier, younger: trajectories of obesity over the life course. Int J Obes 34, 614–623.
3.Peto R (1986) Influence of dose and duration of smoking on lung cancer rates. IARC Sci Publ 74, 23–33.
4.Doll R & Peto R (1978) Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 32, 303–313.
5.Everhart JE, Pettitt DJ, Bennett PH et al. (1992) Duration of obesity increases the incidence of NIDDM. Diabetes 41, 235–240.
6.Pontiroli AE & Galli L (1998) Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidaemia. Acta Diabetologica 35, 130–136.
7.Sakurai Y, Teruya K, Shimada N et al. (1999) Association between duration of obesity and risk of non-insulin-dependent diabetes mellitus. The Sotetsu Study. Am J Epidemiol 149, 256–260.
8.Wannamethee SG & Shaper AG (1999) Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22, 1266–1272.
9.Hekimsoy Z & Oktem IK (2003) Duration of obesity is not a risk factor for type 2 diabetes mellitus, arterial hypertension and hyperlipidemia. Diabetes Obes Metab 5, 432–437.
10.Holbrook TL, Barrett-Connor E & Wingard DL (1989) The association of lifetime weight and weight control patterns with diabetes among men and women in an adult community. Int J Obes 13, 723–729.
11.Perry GS, Byers TE, Mokdad AH et al. (1995) The validity of self-reports of past body weights by US adults. Epidemiology 6, 61–66.
12.Tamakoshi K, Yatsuya H, Kondo T et al. (2003) The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obes Relat Metab Disord 27, 247–252.
14.National Heart Institute (1968) The Framingham Study: An Epidemiological Investigation of Cardiovascular Disease. Bethesda, MD: National Institutes of Health.
15.Dawber TR, Meadors GF & Moore FE Jr (1951) Epidemiological approaches to heart disease: The Framingham Study. Am J Public Health Nations Health 41, 279–286.
16.Kannel WB & Sorlie P (1979) Some health benefits of physical activity. The Framingham Study. Arch Intern Med 139, 857–861.
17.World Health Organization (2006) Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva: WHO.
18.Fisher LD & Lin DY (1999) Time-dependent covariates in the Cox proportional-hazards regression model. Annu Rev Public Health 20, 145–157.
19.StataCorp LP (2007) Stata Survival Analysis and Epidemiological Tables Reference Manual Release 10. College Station, TX: Stata Corporation.
20.Booth ML, Dobbins T, Okely AD et al. (2007) Trends in the prevalence of overweight and obesity among young Australians, 1985, 1997, and 2004. Obesity (Silver Spring) 15, 1089–1095.
21.Felber JP, Golay A, Jequier E et al. (1988) The metabolic consequences of long-term human obesity. Int J Obes 12, 377–389.
22.Groop LC & Eriksson JG (1992) The etiology and pathogenesis of non-insulin-dependent diabetes. Ann Med 24, 483–489.
23.Carlsson S, Persson PG, Alvarsson M et al. (1998) Weight history, glucose intolerance, and insulin levels in middle-aged Swedish men. Am J Epidemiol 148, 539–545.
24.Geer EB & Shen W (2009) Gender differences in insulin resistance, body composition, and energy balance. Gend Med 6, Suppl. 1, 60–75.
25.Blaak E (2001) Gender differences in fat metabolism. Curr Opin Clin Nutr Metab Care 4, 499–502.
26.Centers for Disease Control and Prevention, National Center for Health Statistics (2002) National Health and Nutrition Examination Survey. Atlanta, GA: CDC.
27.Centers for Disease Control and Prevention (2008) State-specific prevalence of obesity among adults – United States. MMWR 57, 765–768.